Isolation and Identification of Vascular Endothelial Cells from Distinct Adipose Depots for Downstream Applications
June 10th, 2022
3.1K views
This protocol details a method for the dissection of mouse adipose depots and the isolation and digestion of respective arteries to liberate and then identify the endothelial cell population. Freshly isolated cells used in downstream applications will advance the understanding of vascular cell biology and the mechanisms of vascular dysfunction.
Overview
This protocol describes a method for dissecting mouse adipose depots and isolating arterial endothelial cells, providing insights into vascular cell biology and dysfunction mechanisms.
Key Study Components
Research Area
- Vascular cell biology
- Mechanisms of vascular dysfunction
- Animal models of disease
Background
- Understanding endothelial cell populations is crucial for vascular research.
- The method can be adapted for various vascular beds.
- Optimizing the digestion protocol is critical for accurate results.
Methods Used
- Dissection and isolation of adipose tissue and arteries
- Mouse model used for in vivo studies
- Flow cytometry for cell identification
Main Results
- Identified endothelial cells using specific markers (CD31 positive, CD45 negative).
- Understood contributions of different vascular beds to cell populations.
- Validated isolation and digestion protocols for functional tests.
Conclusions
- The study provides a valuable method for investigating vascular biology.
- Enhances understanding of vascular dysfunction in disease contexts.
Frequently Asked Questions
What is the main aim of this protocol?
The protocol allows for dissection and isolation of endothelial cells from mouse adipose depots.
How does this research contribute to vascular biology?
It advances understanding of endothelial cell populations and mechanisms of dysfunction.
What key technologies are used in this study?
Dissection techniques and flow cytometry are employed to isolate and analyze cells.
What types of cells are identified in the study?
Endothelial cells are identified using specific surface markers.
Is this protocol applicable to different types of vascular tissue?
Yes, it can be tailored to investigate various vascular beds.
What precautions should be taken while performing the dissections?
Care should be taken to avoid damaging the surrounding vasculature.
What will the fresh cell isolation enable for researchers?
It allows for a wide range of functional tests and deeper investigations into vascular biology.
Executive Industry Relevance
Isolating vascular endothelial cells from distinct adipose depots enables mechanistic interrogation of vascular dysfunction, a key driver in cardiovascular disease progression. This capability supports predictive confidence in early discovery and target validation by providing access to native cell populations for functional and molecular analyses. The method enhances portfolio decision-making by enabling direct comparison of endothelial phenotypes across vascular beds.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct assessment of endothelial cell heterogeneity from specific vascular beds.
- Supports mechanistic de-risking by allowing functional testing of isolated cell populations.
- Facilitates target validation through quantitative marker analysis such as CD31, CD45, and CD36.
- Provides a platform for hypothesis-driven studies on vascular dysfunction mechanisms.
Screening & Assay Development
- Generates validated primary endothelial cell populations for downstream in vitro assays.
- Supports assay standardization by enabling reproducible isolation and identification of viable cells.
- Delivers quantitative outputs via flow cytometry for robust cell population characterization.
- Prepares cells suitable for drug screening and molecular profiling workflows.
Translational & Preclinical Research
- Aligns with disease-relevant models by isolating cells from animal tissues implicated in cardiovascular pathology.
- Enables translational biomarker studies by comparing membrane protein expression across depots.
- Supports continuity from discovery to preclinical validation through functional testing of primary cells.
- Provides mechanistic insights that inform risk-adjusted advancement decisions.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by supplying native endothelial cells for functional, molecular, and screening assays.
- Discovery Biology: Advances hypothesis testing and pathway clarification by enabling direct analysis of vascular cell populations.
- Screening: Delivers reproducible, quantitative cell identification for assay development and compound evaluation.
- Analytics: Provides flow cytometry-based measurements for comparing cell phenotypes and marker expression.
- Translational Research: Bridges animal model findings to disease-relevant human biology through comparative analyses.
- Enterprise Reuse: Establishes a reusable protocol for isolating and characterizing endothelial cells from diverse vascular beds.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular target validation.
- Operational Value: Standardizes cell isolation and identification for scalable, reproducible workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling robust functional assays.
- Portfolio Impact: Supports risk-adjusted prioritization of vascular targets and models.
Implementation Considerations
- Requires expertise in animal dissection and vascular tissue handling.
- Needs access to flow cytometry and cell sorting infrastructure.
- Demands protocol optimization for different vascular beds to ensure cell viability and yield.
- Involves cross-team standardization for reproducible downstream applications.
- Limited to animal models; adaptation to human tissues may require further validation.
Biopharma FAQs
Why does null hypothesis testing matter for CD36 expression analysis?
Null hypothesis testing in CD36 expression quantification enables objective evaluation of differences between endothelial cells from distinct adipose depots, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the endothelial cell sorting workflow?
Isolating arteries from specific adipose depots allows researchers to control for anatomical origin, ensuring that downstream flow cytometry and functional assays reflect true biological differences rather than confounding variables.
What do quantitative flow cytometry measurements enable in this protocol?
Quantitative flow cytometry provides precise identification and enumeration of CD31+/CD45− endothelial cells, enabling reproducible assessment of cell populations and marker expression for downstream functional and molecular analyses.
Why are replication requirements critical for cross-functional vascular studies?
Replication ensures that endothelial cell isolation and marker quantification are consistent across experiments and teams, supporting reliable data integration and collaborative assay development in multi-site R&D environments.
What statistical analysis capabilities are required before implementing flow cytometry outputs?
Robust statistical analysis is needed to interpret flow cytometry data, compare marker expression across depots, and validate findings for decision-making in target validation and assay development pipelines.
Chapters in this video
0:04
Introduction
0:51
Tissue Dissection and Cleaning
4:39
Digestion of Isolated Arteries for Isolation of Endothelial Cells
6:01
Staining of Endothelial Cells Prior to Flow Cytometry
7:06
Results: Identification of Endothelial Cells Following Arterial Tissue Digestion
8:15
Conclusion
